Racial differences in response to antiretroviral therapy for HIV infection: an AIDS clinical trials group (ACTG) study analysis.
about
Nevirapine Concentration in Hair Samples Is a Strong Predictor of Virologic Suppression in a Prospective Cohort of HIV-Infected PatientsHuman immunodeficiency virus-associated lymphomas in the antiretroviral therapy era: Analysis of the National Cancer Data Base.Influence of Sex/Gender and Race on Responses to Raltegravir Combined With Tenofovir-Emtricitabine in Treatment-Naive Human Immunodeficiency Virus-1 Infected Patients: Pooled Analyses of the STARTMRK and QDMRK Studies.Using the multiphase optimization strategy (MOST) to optimize an HIV care continuum intervention for vulnerable populations: a study protocol.Psychiatric symptoms and antiretroviral nonadherence in US youth with perinatal HIV: a longitudinal studyInvestigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic Analysis.Structural Determinants of Antiretroviral Therapy Use, HIV Care Attendance, and Viral Suppression among Adolescents and Young Adults Living with HIVUnderstanding Cross-Sectional Racial, Ethnic, and Gender Disparities in Antiretroviral Use and Viral Suppression Among HIV Patients in the United States.No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United Kingdom.Sex-Related Differences in Inflammatory and Immune Activation Markers Before and After Combined Antiretroviral Therapy Initiation.Trends in Racial and Ethnic Disparities in Antiretroviral Therapy Prescription and Viral Suppression in the United States, 2009-2013.Evaluating the Population Impact of Intervening on Specific Targets to Reduce HIV Racial/Ethnic Disparities in Adulthood: a Conceptual and Methodological Framework.Clinical characteristics and survival outcome of primary effusion lymphoma: A review of 105 patients.Efavirenz Therapeutic Range in HIV-1 Treatment-Naive Participants.Medication beliefs mediate the association between medical mistrust and antiretroviral adherence among African Americans living with HIV/AIDS.
P2860
Q28548003-BD695644-F744-499E-9D07-4E97EADC5B26Q31110269-48F21999-D2EE-441E-86A3-399801B6C78EQ33629439-2529FC08-5FE4-4583-8AF8-FBA20384B58EQ33640486-2D00F95C-0186-4CCB-A46F-7F414AC12713Q35920291-BFF85CBA-7C93-4C52-9D93-06388FF676B5Q35947529-A10ED8D1-7EFB-4462-AFA7-D8A40208ADDDQ35976752-FF8D5A53-2C8E-443B-BBC0-B762D14F8AB8Q37205880-26D6C3D4-8B94-4A8A-8506-DE52CFF1D5F5Q37365060-B7F840FF-4692-42F5-BBB2-920DBF0F48C1Q38858603-DEAA6F02-8173-4AA2-BBCA-CE4AA3DAC272Q39621488-D93CF356-E335-4F39-9077-17760528D0C1Q41921518-450F17C2-FB9F-4029-A81C-748FBA43A60AQ44551214-13FDB2F0-223F-4E80-9EB7-94E761C7F99AQ46600089-AE7EAC36-5194-49CB-A4D9-F36F3592F3A8Q53790780-E6B67D54-EDF1-4BA4-A7F5-A782D2710028
P2860
Racial differences in response to antiretroviral therapy for HIV infection: an AIDS clinical trials group (ACTG) study analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Racial differences in response ...... s group (ACTG) study analysis.
@en
Racial differences in response ...... an AIDS clinical trials group
@nl
type
label
Racial differences in response ...... s group (ACTG) study analysis.
@en
Racial differences in response ...... an AIDS clinical trials group
@nl
prefLabel
Racial differences in response ...... s group (ACTG) study analysis.
@en
Racial differences in response ...... an AIDS clinical trials group
@nl
P2093
P2860
P921
P356
P1476
Racial differences in response ...... s group (ACTG) study analysis.
@en
P2093
Bruce R Schackman
Charles Flexner
Gregory K Robbins
Heather J Ribaudo
Kimberly Y Smith
Margaret A Fischl
Richard Haubrich
Roy M Gulick
Sharon A Riddler
P2860
P304
P356
10.1093/CID/CIT595
P407
P577
2013-09-17T00:00:00Z